{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T17:04:42Z","timestamp":1779987882521,"version":"3.53.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jviromet.2026.115394","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:52:52Z","timestamp":1775145172000},"page":"115394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of sensitivity difference between two widely used HDV RNA quantification assays on the management of HDV-infected patients treated with bulevirtide"],"prefix":"10.1016","volume":"344","author":[{"given":"Val\u00e9rian","family":"Delagarde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athenais","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Dziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Chaghouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Akhavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gordien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Le Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Roulot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9gol\u00e8ne","family":"Brichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jviromet.2026.115394_bib1","article-title":"Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV","volume":"7","author":"Anolli","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jviromet.2026.115394_bib2","article-title":"Collaborative study to establish a world health organization international standard for hepatitis D virus RNA for nucleic acid amplification technology (NAT) \u2013based assays.WHO Report 2013, WHO\/BS\/2013.2227 &,#x9","author":"Chudy","year":"2013","journal-title":"WHO Collab. Study Establ. a Replace. WHO Int. Stand. HBV DNA NAT Assays"},{"key":"10.1016\/j.jviromet.2026.115394_bib3","first-page":"S26","article-title":"Bulevirtide, with or without peg-interferon, in HDV infected patients in a real-life setting. Two-year results from the French multicenter early access program","volume":"76","author":"De Ledinghen","year":"2022","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jviromet.2026.115394_bib4","first-page":"420","article-title":"Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B","volume":"46","author":"Fattovich","year":"2000","journal-title":"Eur. Concert. Action Viral Hepat. (Eur. ). Gut"},{"key":"10.1016\/j.jviromet.2026.115394_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(22)00540-2","article-title":"Real life study of bulevirtide in chronic hepatitis delta: preliminary results of the ANRS HD EP01 BuleDelta prospective cohort","volume":"77","author":"Fontaine","year":"2022","journal-title":"J. Hepatol."},{"issue":"S1","key":"10.1016\/j.jviromet.2026.115394_bib6","first-page":"S380","article-title":"Evaluation of EurobioPlex EBX-071, a new commercial kit for HDV viral load quantification","volume":"78","author":"Gerber","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jviromet.2026.115394_bib7","unstructured":"Haute Autorit\u00e9 de, Sant\u00e9. Prise en charge des personnes infect\u00e9es par le virus de l\u2019h\u00e9patite Delta -. Recommandations \u3008https:\/\/www.has-sante.fr\/jcms\/p_3324682\/fr\/prise-en-charge-des-personnes-infectees-par-les-virus-de-l-hepatite-b-c-ou-d\u3009., 2023."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115394_bib8","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.28772","article-title":"First international external quality assessment for hepatitis delta virus RNA quantification in plasma","volume":"64","author":"Le Gal","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jviromet.2026.115394_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL clinical practice guidelines on hepatitis delta virus","volume":"79","author":"European Association for the Study of the Liver","year":"2023","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.jviromet.2026.115394_bib10","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2009.01.052","article-title":"A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma","volume":"136","author":"Romeo","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviromet.2026.115394_bib11","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jhep.2020.06.038","article-title":"Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta","volume":"73","author":"Roulot","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jviromet.2026.115394_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2025.105850","article-title":"Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: results from a national quality control multicenter study","volume":"180","author":"Salpini","year":"2025","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2026.115394_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2025.105828","article-title":"Accurate quantification using the new RoboGene HDV RNA quantification Kit 3.0: a European multicenter study","volume":"179","author":"Stelzl","year":"2025","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2026.115394_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.104932","article-title":"Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: a European multicenter study","volume":"142","author":"Stelzl","year":"2021","journal-title":"J. Clin. Virol."},{"issue":"4","key":"10.1016\/j.jviromet.2026.115394_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jhep.2024.05.001","article-title":"Bulevirtide monotherapy in patients with chronic HDV: efficacy and safety results through week 96 from a phase III randomized trial","volume":"81","author":"Wedemeyer","year":"2024","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.jviromet.2026.115394_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/HEP.0000000000000584","article-title":"HDV RNA assays: performance characteristics, clinical utility, and challenges","volume":"81","author":"Wedemeyer","year":"2025","journal-title":"Hepatology"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093426000583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093426000583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:37:38Z","timestamp":1779986258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093426000583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":16,"alternative-id":["S0166093426000583"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2026.115394","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of sensitivity difference between two widely used HDV RNA quantification assays on the management of HDV-infected patients treated with bulevirtide","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2026.115394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115394"}}